Movement Disorders
Conference Coverage
Nanoparticle shows promise for ALS
A phase 2 study revealed a significant survival advantage with drug that targets mitochondria.
Conference Coverage
Novel drug significantly reduces tics in Tourette syndrome – without side effects
Ecocipam does not lead to weight gain, anxiety, depression, or tardive dyskinesia, compared with placebo – a factor that may lead to better...
From the Journals
Atypical anxiety offers intervention target in Parkinson’s disease
A systematic review identified a range of anxiety symptoms related to motor and nonmotor symptoms of Parkinson’s disease.
FDA/CDC
FDA advisory panel rejects new ALS drug
The FDA panel raised a number of issues with the clinical trial, including the study’s small sample size and no survival benefit at 24 weeks.
From the Journals
Tremors and memory loss precede Parkinson’s in diverse population
Ethnically diverse study identifies prediagnostic Parkinson’s disease in primary care.
Latest News
‘Robust’ increase in tics during the pandemic explained?
Approximately 85% of teens surveyed said their tic frequency worsened during COVID.
Conference Coverage
Top strategies for preventing tardive dyskinesia
“Inform patients and caregivers of the risk of TD and assess for incipient signs regularly,” Dr. Christoph U. Correll advised.
From the Journals
Imaging links insula and frontal cortex to anxiety in Parkinson’s disease
Electroencephalography showed stronger connections in several brain areas of patients with anxiety compared to those without anxiety
From the Journals
Restless legs syndrome surged early during pandemic
Increased symptom severity in patients with restless legs syndrome was associated with sleep disturbance, depression, and anxiety.
Latest News
Positive phase 3 topline results for early Parkinson’s drug
“The initiation of treatment of patients with Parkinson’s disease represents an area of unmet need due to the side effects associated with current...
Conference Coverage
COVID-19 hospital data: New-onset seizures more common than breakthrough seizures
Altered status in patients should trigger consideration of EEGs, researcher says.